ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 861 filers reported holding ISHARES TR in Q4 2020. The put-call ratio across all filers is 1.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,147 | -2.5% | 33,758 | 0.0% | 0.26% | -9.1% |
Q2 2023 | $4,252 | -1.0% | 33,758 | 0.0% | 0.29% | -12.3% |
Q1 2023 | $4,295 | -3.1% | 33,758 | 0.0% | 0.33% | -14.4% |
Q4 2022 | $4,434 | -99.9% | 33,758 | 0.0% | 0.38% | -1.6% |
Q3 2022 | $3,970,000 | -0.0% | 33,758 | 0.0% | 0.39% | +2.1% |
Q2 2022 | $3,971,000 | -10.5% | 33,758 | -0.9% | 0.38% | -3.6% |
Q1 2022 | $4,438,000 | -15.3% | 34,058 | -0.1% | 0.39% | -21.1% |
Q4 2021 | $5,242,000 | -4.8% | 34,090 | +0.1% | 0.50% | -26.5% |
Q3 2021 | $5,507,000 | -1.2% | 34,058 | 0.0% | 0.68% | +1.5% |
Q2 2021 | $5,574,000 | +12.3% | 34,058 | +3.3% | 0.67% | +0.5% |
Q1 2021 | $4,962,000 | -0.9% | 32,958 | -0.3% | 0.66% | -20.7% |
Q4 2020 | $5,008,000 | +11.9% | 33,058 | 0.0% | 0.84% | -8.1% |
Q3 2020 | $4,477,000 | +8.2% | 33,058 | +9.3% | 0.91% | -4.9% |
Q2 2020 | $4,136,000 | +31.3% | 30,258 | +3.5% | 0.96% | -5.0% |
Q1 2020 | $3,151,000 | -12.4% | 29,248 | -2.0% | 1.01% | +3.5% |
Q4 2019 | $3,597,000 | +42.3% | 29,848 | +18.2% | 0.98% | +30.4% |
Q3 2019 | $2,527,000 | -29.2% | 25,248 | -22.8% | 0.75% | -29.7% |
Q2 2019 | $3,570,000 | -2.4% | 32,715 | 0.0% | 1.06% | -5.5% |
Q1 2019 | $3,657,000 | +60.6% | 32,715 | +38.5% | 1.13% | +210.5% |
Q4 2018 | $2,277,000 | -20.9% | 23,616 | 0.0% | 0.36% | -21.1% |
Q3 2018 | $2,878,000 | +12.9% | 23,616 | 0.0% | 0.46% | -41.0% |
Q2 2018 | $2,549,000 | -0.1% | 23,616 | -1.2% | 0.78% | -3.1% |
Q1 2018 | $2,552,000 | -54.7% | 23,910 | -54.7% | 0.80% | -53.2% |
Q4 2017 | $5,631,000 | -3.1% | 52,738 | +199.7% | 1.72% | -9.8% |
Q3 2017 | $5,812,000 | +6.6% | 17,596 | +0.1% | 1.91% | -1.6% |
Q2 2017 | $5,453,000 | +379.6% | 17,586 | +353.9% | 1.94% | +337.2% |
Q1 2017 | $1,137,000 | +30.2% | 3,874 | +17.8% | 0.44% | +16.2% |
Q4 2016 | $873,000 | -10.3% | 3,289 | -2.2% | 0.38% | -7.3% |
Q3 2016 | $973,000 | +12.4% | 3,364 | 0.0% | 0.41% | +12.6% |
Q2 2016 | $866,000 | +3.8% | 3,364 | +5.2% | 0.37% | +1.9% |
Q1 2016 | $834,000 | -39.4% | 3,198 | -21.3% | 0.36% | -37.5% |
Q4 2015 | $1,376,000 | – | 4,066 | – | 0.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |